Eden Research plc Total Liabilities
Eden Research plc total liabilities. Based on the latest financial reports, Eden Research plc (EDEN) has total liabilities worth GBX2.85 Million GBX (≈ $347.13 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Eden Research plc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Eden Research plc (2004–2026)
Total liabilities of Eden Research plc from 2004 to 2026. This chart illustrates how Eden Research plc's total liabilities have evolved over time, based on quarterly financial data. Explore Eden Research plc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Eden Research plc Competitors by Total Liabilities
The table below lists competitors of Eden Research plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LeddarTech Holdings Inc
NASDAQ:LDTC
|
USA | $134.89 Million |
|
Southstone Minerals Ltd
V:SML
|
Canada | CA$6.07 Million |
|
Krakchemia SA
WAR:KCH
|
Poland | zł81.52 Million |
|
Duearity AB
ST:DEAR
|
Sweden | Skr22.38 Million |
|
Tortilla Mexican Grill PLC
LSE:MEX
|
UK | GBX56.74 Million |
|
Challenger Energy Group PLC
LSE:CEG
|
UK | GBX13.66 Million |
|
Blaize Holdings, Inc. Warrants
NASDAQ:BZAIW
|
USA | $63.24 Million |
Liability Composition Analysis (2004–2026)
This chart breaks down Eden Research plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Eden Research plc asset portfolio.
Liquidity & Leverage Metrics
Eden Research plc Total Liabilities Ratios Explained
Eden Research plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eden Research plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eden Research plc (2004–2026)
The table below shows the annual total liabilities of Eden Research plc from 2004 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | GBX3.91 Million ≈ $476.11 |
+9.66% |
| 2024-12-31 | GBX3.57 Million ≈ $434.15 |
+17.03% |
| 2023-12-31 | GBX3.05 Million ≈ $370.97 |
+40.59% |
| 2022-12-31 | GBX2.17 Million ≈ $263.86 |
-1.32% |
| 2021-12-31 | GBX2.20 Million ≈ $267.39 |
+10.13% |
| 2020-12-31 | GBX2.00 Million ≈ $242.78 |
+31.53% |
| 2019-12-31 | GBX1.52 Million ≈ $184.59 |
+60.90% |
| 2018-12-31 | GBX942.87K ≈ $114.72 |
-54.49% |
| 2017-12-31 | GBX2.07 Million ≈ $252.10 |
+100.63% |
| 2016-12-31 | GBX1.03 Million ≈ $125.66 |
+37.23% |
| 2015-12-31 | GBX752.55K ≈ $91.56 |
+64.20% |
| 2014-12-31 | GBX458.30K ≈ $55.76 |
-46.34% |
| 2013-12-31 | GBX854.09K ≈ $103.92 |
-59.22% |
| 2012-12-31 | GBX2.09 Million ≈ $254.86 |
-27.97% |
| 2011-12-31 | GBX2.91 Million ≈ $353.82 |
-48.77% |
| 2010-12-31 | GBX5.68 Million ≈ $690.61 |
+37.80% |
| 2009-12-31 | GBX4.12 Million ≈ $501.16 |
+24.44% |
| 2008-12-31 | GBX3.31 Million ≈ $402.72 |
+19.83% |
| 2007-12-31 | GBX2.76 Million ≈ $336.09 |
-14.34% |
| 2006-12-31 | GBX3.22 Million ≈ $392.36 |
+45.99% |
| 2005-12-31 | GBX2.21 Million ≈ $268.76 |
+96.65% |
| 2004-12-31 | GBX1.12 Million ≈ $136.66 |
-- |
About Eden Research plc
Eden Research plc, together with its subsidiaries, biopesticides and plastic-free encapsulation technology for use in the global crop protection, animal health, and consumer products industries in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and… Read more